Lamotrigine Tablet
Product Images NDC 16714-196

11 FDA label images from Northstar Rx Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 16714-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Lamotrigine (F432b9ab B725 40f4 A1c4 2b0d198dec28 01)

Structured Formula For Lamotrigine (F432b9ab B725 40f4 A1c4 2b0d198dec28 01)
Chemical structure of Lamotrigine, showing its molecular framework with chlorine substitutions and nitrogen-containing heterocyclic rings.*
FDA Label Image

Lamotrigine Tablet (F432b9ab B725 40f4 A1c4 2b0d198dec28 02)

Lamotrigine Tablet (F432b9ab B725 40f4 A1c4 2b0d198dec28 02)
A Kaplan-Meier failure probability curve comparing Lamotrigine tablets versus placebo over 100 weeks. The Y-axis shows failure probability in percentage, increasing over time. The X-axis represents the study duration in weeks. The graph includes censored data markers and shows the failure probability rising more slowly for Lamotrigine compared to placebo.*
FDA Label Image

Lamotrigine Tablets (F432b9ab B725 40f4 A1c4 2b0d198dec28 03)

Lamotrigine Tablets (F432b9ab B725 40f4 A1c4 2b0d198dec28 03)
A Kaplan-Meier failure probability chart comparing Lamotrigine versus placebo over a period of approximately 80 weeks. The x-axis represents weeks, and the y-axis shows failure probability as a percentage. The graph features two survival curves, one for Lamotrigine and one for placebo, along with censoring marks.*
FDA Label Image

Image (F6d6f71c C94d 4bde Ac57 850998dad74f 388 2)

Image (F6d6f71c C94d 4bde Ac57 850998dad74f 388 2)
Lamotrigine 100 mg oral tablet, round white tablet imprinted with 'ZC' above a score line and '79' below the score line. Manufactured by Northstar Rx LLC.*
FDA Label Image

Image (F6d6f71c C94d 4bde Ac57 850998dad74f 388 3)

Image (F6d6f71c C94d 4bde Ac57 850998dad74f 388 3)
Lamotrigine 80 mg oral tablet imprint with 'ZC' over '80' on one side, indicating the tablet's strength and identification. No other markings or packaging are visible. Labeler is Northstar Rx LLC.*
FDA Label Image

Image (F6d6f71c C94d 4bde Ac57 850998dad74f 388 4)

Image (F6d6f71c C94d 4bde Ac57 850998dad74f 388 4)
Lamotrigine 100 mg oral tablet scored and imprinted with 'ZC' above the score line and '81' below the score line. Labeler shown as Northstar Rx LLC.*
FDA Label Image

Image (F6d6f71c C94d 4bde Ac57 850998dad74f 388 5)

Image (F6d6f71c C94d 4bde Ac57 850998dad74f 388 5)
Lamotrigine 100 mg oral tablet imprinted with 'ZC' on the top half and '82' on the bottom half, round, white, scored. Manufactured by Northstar Rx LLC.*
FDA Label Image

Lamotrigine Tablets Usp, 25 mg (F432b9ab B725 40f4 A1c4 2b0d198dec28 04)

Lamotrigine Tablets Usp, 25 mg (F432b9ab B725 40f4 A1c4 2b0d198dec28 04)
Lamotrigine Tablets, USP 25 mg oral tablets in a package containing 100 tablets. The label includes the NDC 16714-194-01, and states the product is for prescription use only. It highlights a caution to verify the product dispensed and includes pharmacist dispensing instructions. The label shows storage instructions and manufacturer information for Northstar Rx LLC, Memphis, TN, with manufacturing by Zydus Lifesciences Ltd., India.*
FDA Label Image

Lamotrigine Tablets Usp, 100 mg (F432b9ab B725 40f4 A1c4 2b0d198dec28 05)

Lamotrigine Tablets Usp, 100 mg (F432b9ab B725 40f4 A1c4 2b0d198dec28 05)
Label for Lamotrigine Tablets, USP 100 mg oral tablets. The label states "Rx only" and includes the NDC 16714-195-01. It shows a package containing 100 tablets, manufactured by Northstar Rx LLC and produced by Zydus Lifesciences Ltd., India. Storage instructions and cautionary details about dispensing and sealing are included, along with barcodes and contact information.*
FDA Label Image

Lamotrigine Tablets Usp, 150 mg (F432b9ab B725 40f4 A1c4 2b0d198dec28 06)

Lamotrigine Tablets Usp, 150 mg (F432b9ab B725 40f4 A1c4 2b0d198dec28 06)
Packaging label for Lamotrigine Tablets USP 150 mg oral tablets by Northstar Rx LLC. The label displays the product name, strength, dosage form, NDC number 16714-196-01, and package count of 60 tablets. It includes storage instructions, a caution to verify the product dispensed, and pharmacist advice to dispense the medication guide to patients. The label notes manufacturing by Zydus Lifesciences Ltd, India with child-resistant packaging warnings.*
FDA Label Image

Lamotrigine Tablets Usp, 200 mg (F432b9ab B725 40f4 A1c4 2b0d198dec28 07)

Lamotrigine Tablets Usp, 200 mg (F432b9ab B725 40f4 A1c4 2b0d198dec28 07)
Lamotrigine Tablets, USP 200 mg oral tablets packaging label. The label indicates the product contains 60 tablets and is manufactured for Northstar Rx LLC by Zydus Lifesciences Ltd. Instructions include dosage caution, storage guidance at controlled room temperature, child-resistant packaging, and a pharmacist dispensing note. The design shows the Northstar logo and NDC 16714-197-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.